MDRX - Allscripts Healthcare Solutions Non-GAAP EPS of $0.23 beats by $0.04 revenue of $151.9M misses by $0.89M
- Allscripts Healthcare Solutions press release ( NASDAQ: MDRX ): Q3 Non-GAAP EPS of $0.23 beats by $0.04 .
- Revenue of $151.9M (+5.0% Y/Y) misses by $0.89M .
- FY2022 Outlook : Veradigm revenue growth year-over-year between 6% to 7%; Veradigm Adjusted EBITDA growth year-over-year between 10% to 15%; Free cash flow from continuing operations between $110M to $120M.
For further details see:
Allscripts Healthcare Solutions Non-GAAP EPS of $0.23 beats by $0.04, revenue of $151.9M misses by $0.89M